medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2011, Number 04

<< Back Next >>

Ginecol Obstet Mex 2011; 79 (04)

Human Papillomavirus Infection and adolescence

Sam SS, Ortiz CPA, Lira PJ

Language: Spanish
References: 37
Page: 214-224
PDF size: 407.18 Kb.


ABSTRACT

Infection with human papillomavirus has increased dramatically in recent years. The highest prevalence rates are among adolescents and young women, reflecting changes in sexual behavior associated with biological factors in adolescent development. Adolescents who begin sexual activity early are at greater risk of precursor lesions and cervical cancer. There are adolescents with special circumstances, where no early decision should be delayed cervical cytology and in whom it is important to initiate consultations and periodic reviews with a preventive approach. Cervical cancer can be avoided when the diagnosis and treatment of precursor lesions is early. Despite efforts at sex education based on «safe sex» with the correct use of condoms has not been able to reduce the incidence of infections with human papillomavirus in adolescents. While better than nothing, condom use is not 100% reliable. Studies show that consistent and correct use provides protection against the human papillomavirus only 70%. In Mexico, reported an overall ratio of actual use of condoms from 24.6%. It is clear that the physician who provides care for adolescents plays a fundamental role in sex education. The key to future prevention of cervical cancer and its precursor lesions could be the vaccination.


REFERENCES

  1. Schiffman M, Castle PE. Human Papillomavirus: Epidemiology and Public Health. Arch Pathol Lab Med 2003;127:930-934

  2. Emans S, Laufer M, Goldstein D, Pediatric and Adolecent Gynecology. México: McGraw-Hill Interamericana, 2002; 13:388-406

  3. Tatti, S. Colposcopia y patologías del tracto genital en la era de la vacunación. Buenos Aires: Médica Panamericana, 2008;368

  4. Dell D, Chen H, Ahmad F, Stewart D. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000;96:653-656

  5. Moscicki AB, Hills N, Shiboski S. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995.

  6. Kristin M, Jessica A: Human Papillomavirus and Adolescents Girls. Current Women´s Health 2002;2:468-475

  7. Moscicky AB Human Papilloma virus infection in adolescents. Pediatr Clin North Am 1999;46:783-807

  8. Sánchez-Alemán MA. Prevalencia y factores asociados a la infección por Treponema pallidum, virus del herpes simple tipo 2 y virus del papiloma humano en estudiantes universitarios (tesis de Maestría). Cuernavaca: Escuela de Salud Pública de México / Instituto Nacional de Salud Pública, 2001.

  9. Muñoz N, Mendez F, Posso H. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077

  10. Lazcano-Ponce E.. Epidemiology of HPV infection among mexican women with normal cervical cytology. Int. J. Cancer: 2001;91:412-420

  11. Gayet C, Juárez F, Pedrosa LA, Magis C. Uso del condón entre adolescentes mexicanos para la prevención de las infecciones de transmisión sexual. Salud Púb Méx. 2003;45 supl 5:S632-S640

  12. Fundación Mexicana para la Planeación Familiar, AC. Encuesta para el programa Gente Joven 1999. México, D.F. Mexfam.

  13. Instituto Mexicano de la Juventud. Encuesta Nacional de Juventud 2000 Resultados Básicos, México DF: IMJ/SEP 2002

  14. Baseman JG. Koutsky JA, The Epidemiology of human papillomavirus infections. J Clin Virol;32S (2005):S16-S24

  15. Syrjanen S. Puranen M. Human papillomavirus infection in children. The potential role of maternal transmission. Crit Rev Biol Med 2000;11:259-274

  16. Accladious NN, Mandal C. Cervical cytology screening for sexually active teenangers. int J STD AIDS2000;11:648-50

  17. Simsir A. Broocks S. Cochran L. Bourquin P. Loffe OB. Cervicovaginal Smear Abnormalities in Sexually Active Adolescent. Acta Cytol 2002;46:271-6

  18. Moscicki AB, Ellenberg JH, Farhat S. Xu J. Persistence of human papillomavirus infection in HIV-infected and uninfected adolescent girls: risk factors and differences by phylogenetic type. Infect Dis. 2004;190:37-45.

  19. Center for Disease Control and Prevention. Sexually transmitted diseases treatment Guidelines MMWR 2002;51 (No. RR6)

  20. Perlman S, Nakajima S, Hertweek S. Clinical Protocols in Pediatric and Adolescent Gynecology. Parthenon Publishing 2004;36-39.

  21. Ferguson JH, Positive cancer smears in teenage girls, JAMA 1961;178:91-4.

  22. Wright JD, Davila RM, Pinto KR. Cervical dysplasia in adolescents. Obstet Gynecol 2005;106:115-20.

  23. Alan M: Direct medical cost for surgical and medical treatment of condylomata accuminata. Arch Dermatol 2001;137:337-341.

  24. Gayón VE, Hernandez OH, Sam SS. Lombardo AE. Efectividad del preservativo para prevenir el contagio de las infecciones de transmisión sexual. Ginecol Obstet Mex 2008:76:88-96.

  25. Manhart LE, Kourtsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A metanalysis. Sex Trans Dis 2002;29:725-35.

  26. Winer RL. Hughes JP, Qinghua FO,´Reilly S. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006:354:2645-54.

  27. Hogewoning CJ, Bleeker MG, Van den Brule AJ, Voorhorst FJ. Condom use promotes regression of cervical intraepithelial neoplasia and clerarance of human papillomavirus: A randomized clinical trial. Int J Cancer 2003;107:811-6.

  28. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull world Health Organ (online) 2004;82:454-61.

  29. Lazcano Ponce E. Rivera L., Arillo-Santillan E,. Salmeron J. Hernández-Avila M. Muñoz N. Acceptability of a Human Papillomavirus (HPV) trial Vaccine Among Mothers of Adolescents in Cuernavaca México. Arch Med Res 2001;32:243-247.

  30. Bosch FX, Cuzik J, Schiller JT, Garnett GP, Meheus A, Franco EL, Wright TC. Vacunas VPH y cribado en la prevención del Cáncer del cuello uterino. Revista Oficial de la Sociedad Internacional de vacunologia. Revista Oficial de la Sociedad Japonesa de Vacunología. Vaccine 2006;24:53. Disponible en la pagina web:www.sciencedirect.com

  31. Brown D para el FUTURE Study Group Poster presentado en ICAAC, 17 al 20 septiembre de 2007. Chicago. EUA

  32. Stanley M, Prophilactic HPV Vaccines: Underlying Mechanisms, Vaccine 24S3(2006);S3-106:S3-113.

  33. Palefsky J, Giuliano A. On behalf of the male quadrivalent HPV vaccine efficacy trial study group. Efficacy of th Quadrivalent HPV vaccine againsti HPV 6/11/16/18-related genital infection in young men. PS 1-3a EUROGIN 2008. 34. Parr EL, Parr MB, Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex type 2. J. Virol 1997;71:8109-8115.

  34. Breitburd F, Kirnbaue R, Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995;69:3959-3963.

  35. Christensen ND, Reed CA, Immunization with virus-like particles induces long-term protection of rabbits against challenge cottontail rabbit papillomavirus. J Virol 1996;70:960-965.

  36. Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A, Aranda-Flores C. Recomendaciones para la definición de la política de vacunación contra el virus del papiloma en México. Salud Pública de México 2009;51:336-341.




2020     |     www.medigraphic.com